05:31 PM EDT, 10/22/2025 (MT Newswires) -- Medpace ( MEDP ) reported Q3 earnings late Wednesday of $3.86 per diluted share, up from $3.01 a year earlier.

Analysts polled by FactSet expected $3.53.

Revenue for the quarter ended Sept. 30 was $659.9 million, up from $533.3 million a year earlier.

Analysts surveyed by FactSet expected $641 million.

The company now expects 2025 revenue between $2.48 billion and $2.53 billion, versus previous guidance between $2.42 billion and $2.52 billion. Analysts polled by FactSet expect $2.46 billion.

Medpace ( MEDP ) now expects 2025 diluted EPS between $14.60 and $14.86, versus previous guidance between $13.76 and $14.53. Analysts surveyed by FactSet expect $14.05.

Shares of Medpace ( MEDP ) were up more than 18% in after-hours activity.